455 related articles for article (PubMed ID: 27493107)
1. HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil.
da Silva EF; Mazo DF; Oliveira CP; Medeiros RP; Carrilho FJ; Pessôa MG
Ann Hepatol; 2016; 15(5):691-5. PubMed ID: 27493107
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.
Özden HT
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):333-7. PubMed ID: 26703930
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).
Majori S; Baldo V; Tommasi I; Malizia M; Floreani A; Monteiro G; Ferrari A; Accordini A; Guzzo P; Baldovin T
J Travel Med; 2008; 15(5):323-7. PubMed ID: 19006505
[TBL] [Abstract][Full Text] [Related]
5. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
[TBL] [Abstract][Full Text] [Related]
6. [The prevalence of markers for the hepatitis A and B viruses in the population of Gijón between 6 and 25 years old].
Suárez A; Navascués CA; García R; Peredo B; Miguel D; Menéndez MT; Saro C; Román F
Med Clin (Barc); 1996 Apr; 106(13):491-4. PubMed ID: 8992130
[TBL] [Abstract][Full Text] [Related]
7. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
[TBL] [Abstract][Full Text] [Related]
8. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy.
Popovici O; Molnar GB; Popovici F; Janţă D; Pistol A; Azoicăi D
J Gastrointestin Liver Dis; 2016 Mar; 25(1):25-32. PubMed ID: 27014751
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study.
Acikgoz A; Cimrin D; Kizildag S; Esen N; Balci P; Sayiner AA
BMC Infect Dis; 2020 Jul; 20(1):529. PubMed ID: 32698841
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics.
Köse Ş; Ödemiş I; Çelik D; Gireniz Tatar B; Akbulut I; Çiftdoğan DY
Infez Med; 2017 Dec; 25(4):339-343. PubMed ID: 29286012
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.
Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Lascoux-Combe C; Garipuy D; Rosenthal E; Carrieri P; Dabis F; Salmon D
Vaccine; 2011 Nov; 29(47):8656-60. PubMed ID: 21920402
[TBL] [Abstract][Full Text] [Related]
12. Serological markers of hepatitis A, B and C viruses in rural communities of the semiarid Brazilian northeast.
Almeida D; Tavares-Neto J; Vitvitski L; Almeida A; Mello C; Santana D; Tatsch F; Paraná R
Braz J Infect Dis; 2006 Oct; 10(5):317-21. PubMed ID: 17293918
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece.
Michos A; Terzidis A; Kalampoki V; Pantelakis K; Spanos T; Petridou ET
J Med Virol; 2008 May; 80(5):791-7. PubMed ID: 18360892
[TBL] [Abstract][Full Text] [Related]
14. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of hepatitis virus infection markers in HIV-infected patients in Southern Spain].
Cifuentes C; Mira JA; Vargas J; Neukam K; Escassi C; García-Rey S; Gilabert I; González-Monclova M; Bernal S; Pineda JA
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):452-7. PubMed ID: 22541340
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.
Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY
Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579
[TBL] [Abstract][Full Text] [Related]
17. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in the south Brazilian region: metropolitan area of Florianópolis, Santa Catarina.
Voigt AR; Strazer Neto M; Spada C; Treitinger A
Braz J Infect Dis; 2010; 14(1):60-5. PubMed ID: 20428656
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of atopy in children with antibodies against hepatitis A virus and hepatitis B virus.
Kocabaş E; Yapicioğlu H; Yildizdaş D; Güneşer Kendirli S; Burgut R
Turk J Pediatr; 2006; 48(3):189-96. PubMed ID: 17172060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
